Cargando…
A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary intervention
BACKGROUND: Patients with coronary artery disease (CAD) combined with diabetes have a higher risk of cardiovascular events, and high-sensitivity C-reactive protein (hs-CRP)-to-albumin ratio (CAR) is a novel inflammatory biomarker. However, whether the CAR can identify high-risk patients with CAD and...
Autores principales: | Li, Jiawen, Zhu, Pei, Li, Yulong, Yan, Kailun, Tang, Xiaofang, Xu, Jingjing, Yang, Weixian, Qiao, Shubin, Yang, Yuejin, Gao, Runlin, Xu, Bo, Yuan, Jinqing, Zhao, Xueyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901126/ https://www.ncbi.nlm.nih.gov/pubmed/36747210 http://dx.doi.org/10.1186/s13098-022-00977-9 |
Ejemplares similares
-
Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023) -
Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World
por: Yan, Kailun, et al.
Publicado: (2023) -
Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: A large real-world study in China
por: Li, Jiawen, et al.
Publicado: (2023) -
Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
por: Li, Jiawen, et al.
Publicado: (2021) -
Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients
Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary
Intervention
por: Li, Yulong, et al.
Publicado: (2022)